- Home
- ASND vs DUOL Comparison
ASND vs DUOL Comparison
Compare ASND & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- DUOL
- Stock Information
- Founded
- ASND 2006
- DUOL 2011
- Country
- ASND Denmark
- DUOL United States
- Employees
- ASND N/A
- DUOL N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- DUOL Computer Software: Prepackaged Software
- Sector
- ASND Health Care
- DUOL Technology
- Exchange
- ASND Nasdaq
- DUOL Nasdaq
- Market Cap
- ASND 12.0B
- DUOL 13.3B
- IPO Year
- ASND 2015
- DUOL 2021
- Fundamental
- Price
- ASND $209.95
- DUOL $328.27
- Analyst Decision
- ASND Strong Buy
- DUOL Buy
- Analyst Count
- ASND 16
- DUOL 18
- Target Price
- ASND $244.19
- DUOL $410.71
- AVG Volume (30 Days)
- ASND 447.1K
- DUOL 1.4M
- Earning Date
- ASND 11-13-2025
- DUOL 11-05-2025
- Dividend Yield
- ASND N/A
- DUOL N/A
- EPS Growth
- ASND N/A
- DUOL 73.11
- EPS
- ASND N/A
- DUOL 2.46
- Revenue
- ASND $576,332,355.00
- DUOL $885,152,000.00
- Revenue This Year
- ASND $102.31
- DUOL $38.77
- Revenue Next Year
- ASND $76.44
- DUOL $25.92
- P/E Ratio
- ASND N/A
- DUOL $138.88
- Revenue Growth
- ASND 54.50
- DUOL 39.51
- 52 Week Low
- ASND $118.03
- DUOL $256.63
- 52 Week High
- ASND $216.45
- DUOL $544.93
- Technical
- Relative Strength Index (RSI)
- ASND 61.45
- DUOL 54.18
- Support Level
- ASND $205.40
- DUOL $320.63
- Resistance Level
- ASND $212.48
- DUOL $344.00
- Average True Range (ATR)
- ASND 5.96
- DUOL 17.40
- MACD
- ASND 0.37
- DUOL 2.83
- Stochastic Oscillator
- ASND 86.21
- DUOL 66.07
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About DUOL Duolingo Inc.
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.